Pharmacy’s Voice Needs To Be Heard To Gain Committee Approval on Two Pro-Independent Pharmacy Bills and Stop a Pro-PBM Mail Order Bill. IPC is working with the Florida Independent Pharmacy Network & other Florida pharmacy organizations to get grassroots actions to spur the Florida Legislature in the 2018 session to enact pro-pharmacy bills.

The Department of Workers' Comp (DWC) came out with new proposed rules on compounded medications last week. The proposed rules change the definition of the closed formulary to exclude any prescription drug created through compounding, and to require preauthorization for all prescription drugs created through compounding. If adopted, these amendments become effective July 1, 2018.

Under a state of emergency declared by Gov. Edmund G. Brown due to multiple fires in Napa, Sonoma and Yuba Counties (https://www.gov.ca.gov/home.php), the California State Board of Pharmacy reminds pharmacists and pharmacies about pharmacy law provisions that can be of assistance in caring for patients displaced by the emergency relocations.

As required by AB 602 (Bonta, Chapter 139, Statutes of 2017), a list of names of authorized distributors of nonprescription diabetes test devices is now posted on the California State Board of Pharmacy website.

IPC has been working closely with other Pennsylvania pharmacy industry stakeholders, including the Pennsylvania Pharmacists Association (PPA), to monitor Pennsylvania Medicaid's development of a new federally mandated fee-for-service (FFS) prescription reimbursement formula designed to reflect transparent "true cost" to provide Medicaid patients with access to their prescription drug benefit.

IPC has learned that the final version of the Ohio State Annual Appropriations Act signed into law by Ohio Governor John Kasich (R) contained the Senate version which allows Medicaid to move forward with its proposed four (4) tiered, volume based dispensing fee rather than the House proposed flat fee of $10.49.